New Key Statistics Module, Z-Score and F-Score
NAS:HRMY Key Ratios
Market Cap $ M | 1,740.95 |
Enterprise Value $ M | 1,529.35 |
P/E(ttm) | 13.27 |
PE Ratio without NRI | 10.54 |
Forward PE Ratio | 21.13 |
Price/Book | 3.38 |
Price/Sales | 2.96 |
Price/Free Cash Flow | 8.79 |
Price/Owner Earnings | 24.15 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 617.00 |
EPS (TTM) $ | 2.31 |
Beneish M-Score | -2.35 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 49.70 |
EV-to-EBIT | 7.17 |
EV-to-EBITDA | 6.43 |
PEG | -- |
Shares Outstanding M | 56.79 |
Net Margin (%) | 22.30 |
Operating Margin % | 32.98 |
Pre-tax Margin (%) | 30.35 |
Quick Ratio | 3.07 |
Current Ratio | 3.11 |
ROA % (ttm) | 17.60 |
ROE % (ttm) | 28.78 |
ROIC % (ttm) | 41.19 |
Dividend Yield % | -- |
Altman Z-Score | 4.94 |
HRMY Number of Guru Trades
HRMY Volume of Guru Trades
Gurus Latest Trades with NAS:HRMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HRMY is held by these investors
Total 2
Harmony Biosciences Holdings Inc Insider Transactions
No Available Data
News about NAS:HRMY
Total 0- 1